ERA is in the process of being migrated to Scholaris, a Canadian shared institutional repository service (https://scholaris.ca). If you encounter any issues depositing to ERA, please contact erahelp@ualberta.ca
- 330 views
- 372 downloads
Platelet-associated angiogenesis regulating factors: a pharmacological perspective
-
- Author(s) / Creator(s)
-
Platelets, in addition to maintaining hemostasis, also stimulate angiogenesis by generating and releasing, upon activation, factors that promote the growth of new blood vessels. To date, at least 20 angiogenesis-regulating factors have been identified in platelets, including both promoters and inhibitors. Platelet-derived angiogenesis regulators promote angiogenesis during wound healing, tumor growth, and in response to ischemia. Within platelets, angiogenesis regulators are primarily stored in alpha-granules, but are also found in the cytosol or derived from membrane lipids. Their release can be inhibited pharmacologically by anti-platelet agents, which consequently suppress platelet-stimulated angiogenesis. Several years ago, our research group discovered that platelets generate the angiogenesis inhibitor angiostatin independent of the activation state of platelets, and that platelet-derived angiostatin serves to limit the angiogenesis-stimulating effects of platelets. In this review, we summarize the current knowledge of platelet-associated angiogenesis regulators, how they impact angiogenesis, and how they are controlled pharmacologically.
-
- Date created
- 2012
-
- Type of Item
- Review
-
- License
- © 2012 NRC Research Press. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.